Patent ID: 7745454
Filing Date: 2010-06-29
Classification: A61P,C07D

Abstract:
1. A method for treating a disease in a patient, said disease selected from the group consisting of asthma and multiple sclerosis which method comprises administering to said patient a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound of formula (Ia) or (Ib): wherein: Ar R is selected from the group consisting of alkyl, alkoxy, halo, and mono- and dialkyl-amino; q is an integer from 0 to 2; R Y is CH or N; R X is selected from the group consisting of hydroxyl, alkoxy and substituted alkoxy; or an enantiomer, diastereomer or pharmaceutically acceptable salt thereof; wherein the compound of Formula I(a) or I(b) has a binding affinity to VLA-4 as expressed by an IC